Cargando…

Rheumatherapie und Lungentoxizität

Rheumatic diseases are treated with manifold different drugs that can potentially be pneumotoxic. Adverse effects of drug therapy may induce a wide variety of bronchopulmonary and pleural disorders, which can have a life-threatening course. These side effects rarely have pathognomonic features; ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiber, J., Müller-Ladner, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101753/
https://www.ncbi.nlm.nih.gov/pubmed/32288712
http://dx.doi.org/10.1007/s10405-018-0209-3
_version_ 1783511689410379776
author Schreiber, J.
Müller-Ladner, U.
author_facet Schreiber, J.
Müller-Ladner, U.
author_sort Schreiber, J.
collection PubMed
description Rheumatic diseases are treated with manifold different drugs that can potentially be pneumotoxic. Adverse effects of drug therapy may induce a wide variety of bronchopulmonary and pleural disorders, which can have a life-threatening course. These side effects rarely have pathognomonic features; therefore, drug-induced diseases are relevant differential diagnoses of pulmonary manifestations of rheumatic diseases, infections, and other independent genuine pulmonary diseases. Diagnosis is based mainly on verification of a compatible disease pattern and exclusion of differential diagnoses, as well as on assessment of the temporal relationship and the consequences of drug abstention.
format Online
Article
Text
id pubmed-7101753
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-71017532020-03-31 Rheumatherapie und Lungentoxizität Schreiber, J. Müller-Ladner, U. Pneumologe (Berl) Leitthema Rheumatic diseases are treated with manifold different drugs that can potentially be pneumotoxic. Adverse effects of drug therapy may induce a wide variety of bronchopulmonary and pleural disorders, which can have a life-threatening course. These side effects rarely have pathognomonic features; therefore, drug-induced diseases are relevant differential diagnoses of pulmonary manifestations of rheumatic diseases, infections, and other independent genuine pulmonary diseases. Diagnosis is based mainly on verification of a compatible disease pattern and exclusion of differential diagnoses, as well as on assessment of the temporal relationship and the consequences of drug abstention. Springer Medizin 2018-09-25 2018 /pmc/articles/PMC7101753/ /pubmed/32288712 http://dx.doi.org/10.1007/s10405-018-0209-3 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Leitthema
Schreiber, J.
Müller-Ladner, U.
Rheumatherapie und Lungentoxizität
title Rheumatherapie und Lungentoxizität
title_full Rheumatherapie und Lungentoxizität
title_fullStr Rheumatherapie und Lungentoxizität
title_full_unstemmed Rheumatherapie und Lungentoxizität
title_short Rheumatherapie und Lungentoxizität
title_sort rheumatherapie und lungentoxizität
topic Leitthema
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101753/
https://www.ncbi.nlm.nih.gov/pubmed/32288712
http://dx.doi.org/10.1007/s10405-018-0209-3
work_keys_str_mv AT schreiberj rheumatherapieundlungentoxizitat
AT mullerladneru rheumatherapieundlungentoxizitat